Autonomix Medical Inc (AMIX)

$0.73 0.00 (-0.45%)
Market Cap 4.52M
Revenue (ttm) 0.00
Net Income (ttm) -11.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 126,800
Avg Vol 367,678
Day's Range N/A - N/A
Shares Out 6.19M
Stochastic %K 11%
Beta -2.76
Analysts Strong Sell
Price Target $6.60

Company Profile

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related diso...

Industry: Medical Devices
Sector: Healthcare
Phone: 713 588 6150
Address:
21 Waterway Avenue, Suite 300, The Woodlands, United States
Rebelking
Rebelking Nov. 14 at 6:21 PM
$AMIX likely cycle down to .50c.
0 · Reply
Rebelking
Rebelking Nov. 14 at 6:20 PM
$AMIX when will this be cheap? no income, no good outcome.
0 · Reply
Rebelking
Rebelking Nov. 14 at 3:48 PM
$AMIX No volume on this fck stick stock
0 · Reply
APEDM
APEDM Nov. 13 at 1:46 AM
$AMIX https://www.sec.gov/Archives/edgar/data/1617867/000143774925034517/amix20250930_10q.htm
0 · Reply
Rebelking
Rebelking Nov. 11 at 8:02 PM
$AMIX hey management. what’s the story? something expressive and interesting. something daily. something helpful.
0 · Reply
Rebelking
Rebelking Nov. 11 at 7:40 PM
$AMIX are they working with a robotics company?
0 · Reply
Rebelking
Rebelking Nov. 11 at 2:38 PM
$AMIX management, where are you? My goodness.
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 10 at 6:03 PM
🚀 New Signal ✅ 🪙 $AMIX 🗓️ Nov 10, 2025 💵 Entry: $0.8037 🎯 Target (Opt.): $0.9267 (+15.30%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
Rebelking
Rebelking Nov. 10 at 5:18 PM
$AMIX big bag of …
0 · Reply
APEDM
APEDM Nov. 9 at 3:53 AM
$AMIX
1 · Reply
Latest News on AMIX
Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

Oct 24, 2025, 9:00 AM EDT - 21 days ago

Autonomix Medical, Inc. Featured in Two Innovation in Interventional Cardiology Podium Presentations at the Transcatheter Cardiovascular Therapeutics® (TCT®) Annual Scientific Conference

Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit

Oct 16, 2025, 9:15 AM EDT - 4 weeks ago

Autonomix Medical, Inc. to Highlight Innovative Nerve-Sensing and Ablation Platform at the 2025 Maxim Growth Summit

Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

Oct 9, 2025, 8:45 AM EDT - 5 weeks ago

Autonomix Medical, Inc. Granted U.S. Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Oct 2, 2025, 8:45 AM EDT - 6 weeks ago

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment

Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System

Sep 29, 2025, 9:15 AM EDT - 6 weeks ago

Autonomix Medical, Inc. Initiates Good Laboratory Practice (GLP) Study for Sensing and RF Ablation System

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment

Sep 4, 2025, 9:00 AM EDT - 2 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment

Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study

Sep 3, 2025, 8:30 AM EDT - 2 months ago

Autonomix Medical, Inc. Demonstrates Sustained Pain Reduction, Quality of Life Gains and 100% Zero Opioid Use in Longer-Term Post Hoc Analysis from PoC 1 Study

Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:30 AM EDT - 2 months ago

Autonomix Medical, Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.

Aug 18, 2025, 9:15 AM EDT - 3 months ago

Autonomix Medical, Inc. to Participate in Virtual Investor Webinar Hosted by Ladenburg Thalmann & Co. Inc.

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Aug 15, 2025, 9:00 AM EDT - 3 months ago

Autonomix Medical, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech

Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies

Aug 14, 2025, 8:30 AM EDT - 3 months ago

Autonomix Medical, Inc. Finalizes Design Review of First-Ever Intravascular Nerve Sensing Catheter in Key Step Toward U.S. Clinical Studies

Autonomix Medical, Inc. Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Jul 22, 2025, 8:45 AM EDT - 4 months ago

Autonomix Medical, Inc. Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

Jul 21, 2025, 8:45 AM EDT - 4 months ago

Autonomix Medical, Inc. Granted New U.S. Patent to Advance Minimally Invasive, Nerve-Focused Treatments Across High-Need Indications

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Jun 30, 2025, 8:30 AM EDT - 4 months ago

Autonomix Medical, Inc. Treats First Patient in Follow-On Market Expansion Phase (“PoC 2”) of Proof-of-Concept Human Clinical Study

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Jun 27, 2025, 8:00 AM EDT - 5 months ago

Autonomix Medical, Inc. Granted New U.S. Patent for Innovative Catheter-Based Platform Technology

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

Jun 5, 2025, 8:45 AM EDT - 5 months ago

Autonomix Medical, Inc. Granted Approval to Expand Proof-of-Concept Human Clinical Study, Doubling Potential Addressable Market Beyond Pancreatic Cancer Pain

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

May 15, 2025, 8:30 AM EDT - 6 months ago

Autonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform Technology

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

May 14, 2025, 9:20 AM EDT - 6 months ago

Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell Event

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

May 13, 2025, 9:20 AM EDT - 6 months ago

Brad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable Market

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

May 5, 2025, 8:30 AM EDT - 6 months ago

Autonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

May 1, 2025, 9:25 AM EDT - 7 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer Pain

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Apr 30, 2025, 8:15 AM EDT - 7 months ago

Autonomix Medical, Inc. Reports Positive Outcomes in Initial Phase of First-in-Human Proof-of-Concept Trial in Pancreatic Cancer Pain and Initiates Market Expansion Study for Visceral Cancer Pain

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Apr 24, 2025, 8:30 AM EDT - 7 months ago

Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Apr 17, 2025, 5:00 PM EDT - 7 months ago

Autonomix Medical, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Apr 16, 2025, 8:30 AM EDT - 7 months ago

Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Apr 8, 2025, 8:15 AM EDT - 7 months ago

Autonomix Medical, Inc. Engages Leading Medical Experts to Guide U.S. Clinical and Regulatory Path in Pancreatic Cancer Pain

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)

Apr 3, 2025, 8:30 AM EDT - 8 months ago

Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology

Mar 20, 2025, 8:30 AM EDT - 8 months ago

Autonomix Medical, Inc. Granted U.S. Patent Covering Sensing Data Collection and Processing with Company's Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Mar 14, 2025, 8:30 AM EDT - 8 months ago

Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting

Feb 20, 2025, 8:30 AM EST - 9 months ago

Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Feb 13, 2025, 8:00 AM EST - 9 months ago

Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Jan 24, 2025, 8:45 AM EST - 10 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Jan 17, 2025, 8:00 AM EST - 10 months ago

Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Jan 15, 2025, 8:30 AM EST - 10 months ago

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Jan 13, 2025, 8:30 AM EST - 10 months ago

Autonomix Medical, Inc. Announces Abstract Highlighting Preliminary Positive Clinical Results Accepted at The Society of Interventional Oncology (SIO) 2025 Annual Scientific Meeting

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Dec 30, 2024, 8:30 AM EST - 11 months ago

Autonomix Medical, Inc. Announces U.S. Patent Granted Covering the Treatment of Cancerous Tumors and Cancer Related Pain with Company's Proprietary Catheter-Based Technology

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Dec 5, 2024, 8:30 AM EST - 1 year ago

Autonomix Medical, Inc. Achieves Design Lock for RF Ablation Catheter Following Successful Completion of Animal Testing, Continuing Progress Toward a U.S. Pivotal Trial in 2025

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

Nov 25, 2024, 4:00 PM EST - 1 year ago

Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

Nov 22, 2024, 9:15 AM EST - 1 year ago

Autonomix Medical, Inc. Announces Pricing of $9.0 Million Underwritten Public Offering

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Nov 11, 2024, 8:00 AM EST - 1 year ago

Autonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

Oct 30, 2024, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

Oct 28, 2024, 12:06 PM EDT - 1 year ago

Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher

Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday?

Oct 28, 2024, 11:08 AM EDT - 1 year ago

Why Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday?

Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th

Oct 25, 2024, 11:30 AM EDT - 1 year ago

Autonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30th

Autonomix Announces Reverse Stock Split

Oct 22, 2024, 8:30 AM EDT - 1 year ago

Autonomix Announces Reverse Stock Split

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

Oct 8, 2024, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum

Sep 20, 2024, 8:30 AM EDT - 1 year ago

Autonomix Selected to Present at the 2024 Octane Medical Innovation Forum

Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference

Aug 27, 2024, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment Conference

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress

Aug 21, 2024, 8:30 AM EDT - 1 year ago

Autonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual Congress

Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Autonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term Milestones

Rebelking
Rebelking Nov. 14 at 6:21 PM
$AMIX likely cycle down to .50c.
0 · Reply
Rebelking
Rebelking Nov. 14 at 6:20 PM
$AMIX when will this be cheap? no income, no good outcome.
0 · Reply
Rebelking
Rebelking Nov. 14 at 3:48 PM
$AMIX No volume on this fck stick stock
0 · Reply
APEDM
APEDM Nov. 13 at 1:46 AM
$AMIX https://www.sec.gov/Archives/edgar/data/1617867/000143774925034517/amix20250930_10q.htm
0 · Reply
Rebelking
Rebelking Nov. 11 at 8:02 PM
$AMIX hey management. what’s the story? something expressive and interesting. something daily. something helpful.
0 · Reply
Rebelking
Rebelking Nov. 11 at 7:40 PM
$AMIX are they working with a robotics company?
0 · Reply
Rebelking
Rebelking Nov. 11 at 2:38 PM
$AMIX management, where are you? My goodness.
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 10 at 6:03 PM
🚀 New Signal ✅ 🪙 $AMIX 🗓️ Nov 10, 2025 💵 Entry: $0.8037 🎯 Target (Opt.): $0.9267 (+15.30%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
Rebelking
Rebelking Nov. 10 at 5:18 PM
$AMIX big bag of …
0 · Reply
APEDM
APEDM Nov. 9 at 3:53 AM
$AMIX
1 · Reply
coolmate25
coolmate25 Nov. 7 at 6:33 PM
$AMIX Humanity is dead right now. Im waiting on one of my stock to get sold before I hit 10k more . This is the perfect price to bring your average down and I wish Autonomix will submit their FDA paperwork soon.
0 · Reply
Rebelking
Rebelking Nov. 7 at 4:36 PM
$AMIX no news, we lose.
0 · Reply
Rebelking
Rebelking Nov. 7 at 4:16 PM
$AMIX at -8% per day we have ten days left. bottom is $0.
0 · Reply
Rebelking
Rebelking Nov. 7 at 3:22 PM
$AMIX https://stocks.apple.com/ARQkT5hNLR4y5eXWsNtxAMw when’s the next one?
0 · Reply
Rebelking
Rebelking Nov. 7 at 4:22 AM
$AMIX https://www.instagram.com/reel/DKey6s9Iwhh/?igsh=MzRlODBiNWFlZA==
0 · Reply
coolmate25
coolmate25 Nov. 6 at 3:59 PM
$AMIX Come on professionals, this is a strong buy candidate Not sell , I mean why would someone be selling at this stage ? Let it hit back to $2 .
0 · Reply
Rebelking
Rebelking Nov. 5 at 4:20 PM
$AMIX the bottom is $0.00
0 · Reply
APEDM
APEDM Nov. 5 at 3:33 PM
$AMIX issuance of more than 20% of the Company’s issued and outstanding common stock pursuant
2 · Reply
Rebelking
Rebelking Nov. 5 at 3:21 PM
$AMIX leadership needs to go. what do you think?
0 · Reply
GaryBx105
GaryBx105 Nov. 5 at 3:07 PM
$AMIX same old story. great product with huge potential being screwed by vulture capitalists because of periodic need to raise funds.
0 · Reply
APEDM
APEDM Nov. 5 at 2:53 PM
$AMIX It seems to be offering…
0 · Reply
APEDM
APEDM Nov. 5 at 3:35 AM
$AMIX 10,000 shares at 0.9
0 · Reply